PA

Perceptive Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 264.28%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+264.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.52B
AUM Growth
-$1.75B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
173
New
Increased
Reduced
Closed

Top Buys

1
+$194M
2
+$68.7M
3
+$68.4M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$62.1M
5
SWTX
SpringWorks Therapeutics
SWTX
+$52.6M

Top Sells

1
+$116M
2
+$100M
3
+$90.4M
4
NVTA
Invitae Corporation
NVTA
+$87.4M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$87.3M

Sector Composition

1 Healthcare 84.16%
2 Financials 0.49%
3 Industrials 0.21%
4 Consumer Discretionary 0.02%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.21M 0.02%
300,000
127
$1.15M 0.02%
66,655
128
$945K 0.01%
+500,000
129
$755K 0.01%
+27,000
130
$573K 0.01%
+133,066
131
$513K 0.01%
+1,123
132
$335K ﹤0.01%
+10,000
133
$242K ﹤0.01%
667
134
– –
-62,500
135
– –
-1,050,003
136
– –
-20,000
137
– –
-400,000
138
– –
-1,195,336
139
– –
-1,385,720
140
– –
-780,007
141
– –
0
142
– –
-15,000
143
– –
-400,000
144
– –
0
145
– –
-13,461,538
146
– –
-1,400,000
147
– –
-25,000
148
– –
-385,000
149
– –
-77,500
150
– –
-350,000
3 4 5
6
7